thymoquinone has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Mahmoudy, A; El-Sayed, M; Matsuyama, H; Shiina, T; Shimizu, Y; Takewaki, T | 1 |
| El-Mahmoudy, A; Matsuyama, H; Nikami, H; Shiina, T; Shimizu, Y; Takewaki, T | 1 |
2 other study(ies) available for thymoquinone and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Successful abrogation by thymoquinone against induction of diabetes mellitus with streptozotocin via nitric oxide inhibitory mechanism.
Topics: Animals; Benzoquinones; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; I-kappa B Proteins; Insulin; Macrophages, Peritoneal; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; p38 Mitogen-Activated Protein Kinases; Pancreas; Rats; Rats, Wistar; Streptozocin; Transcription Factor RelA | 2005 |
Macrophage-derived cytokine and nitric oxide profiles in type I and type II diabetes mellitus: effect of thymoquinone.
Topics: Animals; Benzoquinones; Blood Glucose; Cytokines; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Immunologic Factors; Interleukin-1; Macrophages, Peritoneal; Male; Nitric Oxide; Nitrites; Rats; Rats, Inbred OLETF; Tumor Necrosis Factor-alpha | 2005 |